Level IV Body Armor

EXO-Defense Resister-4 Level IV Body Armor Plates

July 13, 2017
Comments off

OuterArmor Tactical Exo-Defense Resister Series Level IV Body Armor

  • The OuterArmor Tactical Resister Series Level IV Body Armor plates are cutting edge, ballistic technology.
  • Exo-Defense Resister brand is your best life-saving value available bar none!
  • Super-light plates that afford the lightest, most comfortable protection in a Stand-Alone Rifle & Pistol threat mitigation plate.
  • Multi-Shot Rated
  • Meets U.S. NIJ Standard–0101.06.

ARMOR PIERCING MITIGATION. The OuterArmor Exo-Defense Resister brand is your best life-saving value available bar none!

The OuterArmor Tactical Resister-4 (R4) Level IV Body Armor plate is cutting edge, ballistic technology. This Level IV Body Armor plate affords Armor Piercing Rifle Protection in one of the lightest available Stand Alone Plates available. Rifle and Multi-Shot rated! Other companies sell this level of armor-piercing ballistic plate technology for $400.00-750.00 per plate!

  • The Resister-4 Level IV plates will defeat most commonly used Armor Piercing Rifle rounds
  • Plate size is 10 x 12 x 0.86″
  • TOTAL weight  5.6  lbs per plate
  • Multi-shot and rifle rated, light enough for women and kids
  • Meets U.S. NIJ Standard–0101.06. Please visit the mfr. site for more info.

About The Manufacturer

OuterArmor Tactical’s designer knows a thing or two about metallic plate armor from Up-Armoring vehicles and redoubt locations. He was contacted and tasked by the U.S Army’s (JIEDTF) between 2004 and 2009 to design and manufacture a new Top-Gunner turret system for the Humvee, Rhino trucks, and Stryker combat vehicles that would more fully protect our soldiers. He designed (by special request) other equipment and accessories currently in use by the U.S. Military Special Forces Operators and SWAT. www.outerarmortactical.com.

Please visit the manufacturer website for more technical specs, certifications, standards and ballistics at OuterArmorTactical.com.

Comments are closed.